Physician
DR RS Kids Pediatrics LLC
DR RS Kids Pediatrics LLC was paid $1.11M by Medicaid between Jan 2018 and Nov 2024, across 46 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoDR RS KIDS PEDIATRICS LLC
CLIFTON, NJ 07012
CLIFTON, NJ 07012
33aNPI1598274367assigned 09/25/2017
33bProvider typePediatrics Physician
28Total paid$1.11M
24GClaims39,289
24DCodes billed46
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in New Jersey
Rank by total paid#115 of 549
Median peer was paid$154K
This provider vs. median7.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,762 | $85K | |
| 2019 | 3,801 | $123K | |
| 2020 | 3,766 | $114K | |
| 2021 | 5,657 | $161K | |
| 2022 | 9,053 | $229K | |
| 2023 | 9,736 | $240K | |
| 2024incomplete | 4,514 | $156K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 6,234 | 5,073 | $423K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 3,841 | 3,411 | $329K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.9% | 1,287 | 1,274 | $110K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.1% | 483 | 459 | $45K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.0% | 558 | 533 | $44K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.5% | 2,359 | 2,267 | $27K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.0% | 2,154 | 2,011 | $22K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 1,813 | 1,692 | $21K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.7% | 1,337 | 990 | $19K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 391 | 361 | $14K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.2% | 1,138 | 1,112 | $13K |
| 92551 | <1% | 824 | 787 | $8K |
34 more codes
| 92558 | <1% | 943 | $7K | |
| 99401 | <1% | 803 | $5K | |
| 96127 | <1% | 963 | $4K | |
| 90461 | <1% | 330 | $3K | |
| 99173 | <1% | 1,213 | $2K | |
| 92567 | <1% | 140 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 109 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 40 | $1K |
| 96161 | <1% | 451 | $943.18 | |
| 90688 | <1% | 632 | $893.79 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $768.96 |
| 90686 | <1% | 55 | $602.79 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 37 | $471.55 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 25 | $344.28 |
| 96160 | <1% | 217 | $285.96 | |
| 90670 | <1% | 160 | $241.38 | |
| 99177 | <1% | 121 | $196.41 | |
| 94664 | <1% | 13 | $177.21 | |
| 90474 | <1% | 15 | $151.34 | |
| 90633 | <1% | 30 | $145.58 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 27 | $118.48 |
| 99000 | <1% | 2,485 | $102.44 | |
| 90698 | <1% | 54 | $92.70 | |
| 90680 | <1% | 41 | $88.64 | |
| 81002 | <1% | 69 | $37.67 | |
| 99072 | <1% | 7,691 | $24.60 | |
| 97802 | <1% | 18 | $22.50 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 13 | $21.92 |
| 83655 | <1% | 22 | $14.54 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 21 | $8.00 |
| 90677 | 0% | 12 | $0.00 | |
| 90744 | 0% | 12 | $0.00 | |
| 90671 | 0% | 48 | $0.00 | |
| 90661 | 0% | 48 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialIQBAL, RAZA (MANAGER)